Sotera Health Co Leases Disclosure
| Year Ended December 31, | |||||||||||||||||
(thousands of U.S. dollars) | 2025 | 2024 | 2023 | ||||||||||||||
Operating lease costs (a) | $ | 13,207 | $ | 13,267 | $ | 13,920 | |||||||||||
| Finance lease costs: | |||||||||||||||||
| Amortization of right of use assets | 6,474 | 8,438 | 8,152 | ||||||||||||||
| Interest on lease liabilities | 6,105 | 6,064 | 4,394 | ||||||||||||||
Total finance lease costs | 12,579 | 14,502 | 12,546 | ||||||||||||||
Total lease costs | $ | 25,786 | $ | 27,769 | $ | 26,466 | |||||||||||
| Year Ended December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Weighted average remaining lease term: | |||||||||||
| Operating leases | 11.1 years | 7.3 years | |||||||||
| Finance leases | 14.9 years | 15.2 years | |||||||||
| Weighted average discount rate: | |||||||||||
| Operating leases | 6.90 | % | 6.57 | % | |||||||
| Finance leases | 6.55 | % | 6.55 | % | |||||||
| Year Ended December 31, | |||||||||||||||||
(thousands of U.S. dollars) | 2025 | 2024 | 2023 | ||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities: | |||||||||||||||||
| Operating cash flows for operating leases | $ | 7,917 | $ | 7,382 | $ | 10,067 | |||||||||||
Operating cash flows for finance leases | 6,332 | 6,277 | 3,988 | ||||||||||||||
| Finance cash flows for finance leases | 3,903 | 8,088 | 1,823 | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
(thousands of U.S. dollars) | 2025 | 2024 | 2023 | ||||||||||||||
| Lease liabilities arising from obtaining right-of-use assets: | |||||||||||||||||
| Operating leases | $ | 10,822 | $ | 10,550 | $ | 4,559 | |||||||||||
| Finance leases | 431 | 36,016 | 14,770 | ||||||||||||||
(thousands of U.S. dollars) | Operating Leases | Finance Leases | Total | ||||||||||||||
| 2026 | $ | 8,134 | $ | 9,689 | $ | 17,823 | |||||||||||
| 2027 | 7,187 | 9,968 | 17,155 | ||||||||||||||
| 2028 | 5,760 | 10,263 | 16,023 | ||||||||||||||
| 2029 | 4,717 | 9,933 | 14,650 | ||||||||||||||
| 2030 | 3,767 | 9,634 | 13,401 | ||||||||||||||
| 2031 and Thereafter | 22,069 | 108,811 | 130,880 | ||||||||||||||
| Total lease payments | 51,634 | 158,298 | 209,932 | ||||||||||||||
| Less imputed interest | (15,978) | (60,998) | (76,976) | ||||||||||||||
| Total lease liabilities | $ | 35,656 | $ | 97,300 | $ | 132,956 | |||||||||||
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.